Addiction journal
Addiction journal
Long-acting buprenorphine with Jo Neale
Long-acting buprenorphine with Jo Neale
Long-acting buprenorphine with Jo Neale
Thursday 8th June 2023
Professor Jo Neale discusses her research on the first 72 hours of long-acting buprenorphine treatment, highlighting varied physical and psychological responses.
26 minutes
Informative
Empowering
Insightful
Hopeful
Supportive
About this podcast
Author:
Addiction journal
Overview:
Categories:
Navigating Alcohol Dependency
Understanding Addiction & Recovery
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
87 (View all)
Do you want to link to this podcast?
Get the buttons here!Long-Acting Buprenorphine: The First 72 Hours with Professor Jo Neale
Episode Overview
- Long-acting buprenorphine offers potential benefits post-COVID-19, reducing the need for daily dosing and pharmacy visits
- Varied individual experiences and reactions to long-acting buprenorphine highlight the complexity of treatment responses
- Understanding the embodied qualitative data provides valuable insights into the multifaceted impact on individuals' well-being
- Findings alert clinicians to the diverse range of effects, potentially reducing anxiety and increasing adherence to treatment
- Implications for further research to explore the complexities of long-acting buprenorphine and its long-term effects
The findings as they stand have useful relevance to clinicians, alerting people to the complex range of effects that may arise from long-acting buprenorphine. Knowing that these reactions can be normal or expected will help to reduce anxiety, potentially increasing adherence to treatment.
What happens when someone starts long-acting buprenorphine treatment? In this episode of Addiction Audio, Dr. Rob Calder sits down with Professor Jo Neale to discuss her latest research on this very question. Professor Neale dives into the mixed bag of experiences people face during the first 72 hours of receiving long-acting buprenorphine, a medication that gained attention during the COVID-19 pandemic for reducing the need for daily pharmacy visits.
From positive physical effects to challenging psychological reactions, Jo's research paints a detailed picture of what patients can expect. She also highlights how this treatment may not be suitable for everyone and underscores the importance of preparing individuals for the initial phase of their medication journey. Using an embodiment and embodied cognition approach, Professor Neale's findings offer valuable insights for clinicians and open doors for further research.
Whether you're a researcher, clinician, or someone with personal experience in addiction, this episode provides a nuanced understanding of how long-acting buprenorphine impacts both the mind and body.